Test Price
2,800 AEDโ Home Collection Available
SMN1 Gene (Spinal Muscular Atrophy Type 2) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Summary โ UAEโs Most Reliable SMA Type 2 Genetic Test
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Pre- and Post-Test Genetic Counselling integrated into the workflow.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SMN1 gene Next-Generation Sequencing (NGS) test definitively diagnoses Spinal Muscular Atrophy Type 2 (SMA Type 2) by analyzing the survival motor neuron 1 gene for deletions, point mutations, and copy number variations. Our ISO 9001:2015 certified laboratory delivers results in 3โ4 weeks with 99.9% diagnostic sensitivity. The test is performed on whole blood, extracted DNA, or a single drop of blood on an FTA card, collected via our mobile phlebotomy service.
| Feature | Our Test (ISO-Certified NGS) | Alternative Methods |
|---|---|---|
| Methodology | Full SMN1 Gene NGS with copy number analysis | MLPA or targeted qPCR only |
| Diagnostic Precision | 99.9% sensitivity; detects point mutations, deletions, and silent carriers | ~95% sensitivity; may miss rare variants |
| Turnaround Time | 3โ4 weeks | 4โ6 weeks |
| Genetic Counselling | Pre- and post-test tele-counselling included | Often not integrated |
| Sample Types | Whole blood, extracted DNA, or FTA card (home collection) | Blood only (clinic visit required) |
Physician Insight & Safety Protocols
โSpinal Muscular Atrophy Type 2 genetic testing via NGS is the gold standard for confirming the diagnosis and guiding informed clinical management. Every SMN1 result must be interpreted alongside the patientโs clinical presentation and family history. I strongly advise pre- and post-test genetic counselling to fully understand inheritance risks and available therapeutic options.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Important Medication Advisory
Do not discontinue any prescribed medications such as nusinersen or risdiplam without explicit approval from your treating neurologist. This genetic test is a diagnostic aid and should never replace ongoing clinical management or emergency care. If your child experiences acute respiratory distress or worsening hypotonia, seek immediate hospital attention.
🛡️ Patient Safety โ Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide informed consent (minors require legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability). Samples not collected in accordance with our ISO cold-chain protocol will be rejected.
- Emergency Red Flags โ Seek Immediate Care if: The patient develops acute respiratory distress, severe hypotonia worsening rapidly, or swallowing difficulties leading to choking or aspiration. This genetic test is not for acute emergencies; proceed directly to the nearest hospital if these signs appear.
Patient FAQ & Clinical Guidance
1. What does the SMN1 gene test for Spinal Muscular Atrophy Type 2 detect?
Answer: The SMN1 NGS test identifies homozygous deletions, point mutations, and copy number variations in the SMN1 gene that cause SMA Type 2, confirming the diagnosis with 99.9% accuracy. It also reveals carrier status in family members, guiding reproductive options and early intervention planning.
2. How is the test performed and what are the sample requirements?
Answer: A certified phlebotomist collects a whole blood sample, extracted DNA, or a single drop of blood on an FTA card during a home visit, ensuring strict cold-chain transport. No fasting or medication adjustments are required. A genetic counselling session is recommended before collection to document family history.
3. Why is genetic counselling essential for this test?
Answer: Genetic counselling translates complex SMN1 results into actionable clinical and family decisions, helping you understand inheritance risks, carrier probabilities, and available treatment or support pathways. Our DHA-licensed counsellors provide secure tele-consultations, fully compliant with UAE data privacy laws.
UAE Regulatory & Data Privacy Adherence
This test is conducted in full compliance with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is encrypted and stored securely, accessed only by authorized healthcare professionals. All clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent.
DNA Labs UAE is licensed by the Dubai Health Authority (DHA Facility License Number: 1143) and operates from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | SMN1 Gene (Spinal Muscular Atrophy Type 2) Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card (home collection) |
| Methodology Used | Next-Generation Sequencing (NGS) with copy number analysis |
| ICD-10-CM Code | G12.1 |
| LOINC Code | 21647-7 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians